For many survivors, the cancer experience changes everything. But alongside the fear and grief, it can also bring unexpected growth—stronger relationships, a clearer sense of purpose, and a deeper appreciation for life.

Many Hodgkin’s survivors live with “chemo brain”—the frustrating mental cloudiness that can linger for years. Learn what causes it, how to manage symptoms, and what strategies can help improve memory and focus.

In this powerful advocacy piece, Phuong Ly Gallagher and Erin Cummings, both cancer survivors and dedicated advocates, share their personal stories to raise awareness in the medical community. Their message is clear: cancer survivorship does not end with remission.

Cancer survivors face a 14% higher risk of developing entirely new cancers (secondary malignancies) compared to the general population, and they account for nearly 19% of all cancer diagnoses in the U.S. Oncology Advanced Practice Providers (APPs) highlight that past treatments, especially radiation and certain chemotherapies like alkylating agents, platinum-based drugs, anthracycline topoisomerase II inhibitors, and even targeted therapies, can contribute to long-term risk.

New research from a large study in Denmark and Sweden, shows that adult survivors of childhood cancer, including those treated for Hodgkin lymphoma, may be at greater risk for severe illness from COVID-19. This increased vulnerability is likely linked to lasting effects from cancer treatments, such as weakened immune systems or damage to organs like the lungs and heart.

For people newly diagnosed with advanced-stage classical Hodgkin lymphoma, choosing a first-line treatment can feel overwhelming. This article reviews the most widely used treatments, outlining how they compare in terms of both effectiveness and long-term side effects. The goal is not just remission but also protecting the quality of life for years to come.

Many long-term Hodgkin lymphoma survivors face an increased risk of developing secondary cancers, often as a result of earlier treatments like chemotherapy or radiation. These risks can emerge years or even decades after treatment, making ongoing awareness and screening a critical part of survivorship care.

WNYC’s Brian Lehrer Show featured an insightful panel discussion on the current landscape of cancer research in the United States.

The University of Cincinnati has launched one of the first oncology-focused primary care clinics specifically for Adolescent and Young Adult (AYA) cancer survivors, those diagnosed between the ages 18 and 39. This new model addresses the complex, long-term health risks survivors face, including second cancers, heart disease, and emotional challenges, by combining oncology knowledge with general preventive care. Early data shows high rates of chronic conditions and a strong need for coordinated, survivor-centered care.

A collaboration between ASCO and the American Cancer Society confirms that the answer is YES. Treatments like anthracyclines, chest radiation, immunotherapy, and targeted therapy can place significant stress on the heart, increasing the risk of long-term issues such as high blood pressure, irregular heartbeat, or even heart failure.